Cabozantinib plus nivolumab and ipilimumab in renal-cell carcinoma - The authors reply Correspondence

  

Authors:	Choueiri, T. K.; Wang, F.; Motzer, R. J.
Title:	Cabozantinib plus nivolumab and ipilimumab in renal-cell carcinoma - The authors reply
Keywords:	ipilimumab; pathology; renal cell carcinoma; kidney neoplasms; kidney tumor; carcinoma, renal cell; cabozantinib; nivolumab; humans; human
Journal Title:	New England Journal of Medicine
Volume:	389
Issue:	5
ISSN:	0028-4793
Publisher:	Massachusetts Medical Society
Date Published:	2023-08-03
Start Page:	477
End Page:	478
Language:	English
PUBMED:	37530836
PROVIDER:	scopus
DOI:	10.1056/NEJMc2306786
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85166076492&doi=10.1056%2fNEJMc2306786&partnerID=40&md5=376b099cae1b62969e094a0576caa1e4
Notes:	Letter -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/208814